Cerity Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Cerity Partners’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Buy	+10,310	New	+$341K	﹤0.01%	2590

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cerity Partners's LKFT Position: Q1 2026 in Review

Cerity Partners opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 10,310 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #2590 among its holdings.

90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Cerity Partners held 10,310 shares of Lakefront Biotherapeutics American Depositary Shares worth $309K as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Cerity Partners position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2590 holding.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.